跳转至内容

尊敬的客户:

目前国际形势复杂多变,关税政策尚不明朗,这可能对我们的产品价格产生一定影响。在此情况下,我们希望就订单事宜与您进行友好沟通。

基于当前的不确定性,如果您选择在此期间下单,我们将保留根据实际情况调整价格的权利。同时,我们也理解市场变化可能给您带来的困扰,因此如果在订单实际发货前因关税政策变动导致价格出现较大波动,默克将与您进行协商讨论并视情况对订单进行调整或取消。

Merck
CN
所有图片(1)

主要文件

H0262

Sigma-Aldrich

Hybri-Max™ HAT培养基补充物 (50×)

lyophilized powder, suitable for hybridoma, BioXtra

别名:

HAT Supplement, Hypoxanthine-Aminopterin-Thymidin (HAT) media supplement

登录查看公司和协议定价

选择尺寸

25 MG
¥1,319.86
200 MG
¥3,601.49
500 MG
¥6,917.80
1 G
¥11,568.31

¥1,319.86


国内现货,预计发货时间2025年4月24日详情


获取大包装报价

选择尺寸

变更视图
25 MG
¥1,319.86
200 MG
¥3,601.49
500 MG
¥6,917.80
1 G
¥11,568.31

About This Item

UNSPSC代码:
12352207
NACRES:
NA.75

¥1,319.86


国内现货,预计发货时间2025年4月24日详情


获取大包装报价

产品名称

Hybri-Max™ HAT培养基补充物 (50×), γ-irradiated, lyophilized powder, BioXtra, suitable for hybridoma

质量水平

无菌性

γ-irradiated

产品线

BioXtra

表单

lyophilized powder

技术

cell culture | hybridoma: suitable

杂质

endotoxin, tested

运输

dry ice

储存温度

−20°C

比较类似商品

查看完整比较结果

显示差异

1 of 4

此商品
700002P700054P700061P
packaging

pkg of 1 × 1 g (700001P-1g), pkg of 1 × 25 mg (700001P-25mg), pkg of 1 × 200 mg (700001P-200mg), pkg of 1 × 500 mg (700001P-500mg)

packaging

pkg of 1 × 5 mg (700002P-5mg)

packaging

pkg of 1 × 25 mg (700054P-25mg), pkg of 1 × 5 mg (700054P-5mg)

packaging

pkg of 1 × 1 mg (700061P-1mg), pkg of 1 × 5 mg (700061P-5mg)

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

form

powder

form

powder

form

powder

form

powder

manufacturer/tradename

Avanti Polar Lipids 700001P

manufacturer/tradename

Avanti Polar Lipids

manufacturer/tradename

Avanti Polar Lipids

manufacturer/tradename

Avanti Polar Lipids

应用

HAT培养基添加剂(50×) Hybri-Max 已用于:
  • 次黄嘌呤-鸟嘌呤磷酸核糖基转移酶 (HPRT) 缺陷型克隆体的选择和验证[1]
  • mAbs(单克隆抗体)制备[2]
  • 基于荧光素酶的生物测定 (LUC)[3]

重悬

用 10 ml 无菌细胞培养基重悬小瓶的内容物。 储备溶液足以制备 500 ml 培养基。 最终工作浓度:100 μM 氨基喋呤, 0.4 μM 氨基喋呤,16 μM 胸苷

法律信息

Hybri-Max is a trademark of Sigma-Aldrich Co. LLC

象形图

Health hazardExclamation mark

警示用语:

Danger

危险声明

危险分类

Acute Tox. 4 Oral - Repr. 1B

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type P2 (EN 143) respirator cartridges


  • 历史批次信息供参考:

    分析证书(COA)

    Lot/Batch Number

    没有发现合适的版本?

    如果您需要特殊版本,可通过批号或批次号查找具体证书。

    已有该产品?

    在文件库中查找您最近购买产品的文档。

    访问文档库

    Geoffrey A Mueller et al.
    Journal of immunology (Baltimore, Md. : 1950), 205(8), 1999-2007 (2020-09-11)
    IgE Abs drive the symptoms of allergic disease upon cross-linking allergens on mast cells or basophils. If the IgE binding sites on the allergens could be identified, it may be useful for creating new forms of immunotherapy. However, direct knowledge
    J H Connolly et al.
    Journal of anatomy, 195 ( Pt 2), 161-171 (1999-10-21)
    The gross and histological appearance and the distribution of T and B lymphocytes and plasma cells are described for lymphoid tissues obtained from 15 platypuses. The spleen was bilobed and surrounded by a thick capsule of collagen, elastic fibres and
    The expression and function of the NKRP1 receptor family in C57BL/6 mice
    Aust J G, et al.
    Journal of Immunology, jimmunol-j0804281 (2009)
    Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta
    Hermanrud C, et al.
    Journal of Immunological Methods, 1-9 (2016)
    Youngkyun Kim et al.
    Clinical & translational immunology, 4(11), e51-e51 (2015-12-19)
    This study was undertaken to develop a novel anti-citrullinated peptide antibody (ACPA) and to investigate its arthritogenicity in a collagen-induced arthritis (CIA) model. The novel ACPA, 12G1, was developed by injecting cyclic citrullinated antigen in mice and subsequently hybridizing the

    相关内容

    Major technological advances have made the production of monoclonal antibodies quicker and more efficient. There are three established platforms for antibody discovery. We offer reagents for production of monoclonal antibody libraries using each of these techniques.

    技术方面的重大进展让单克隆抗体生产更快速高效。现有三个成熟的抗体发现平台。我们提供基于不同技术生产单克隆抗体所需的试剂。

    我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系客户支持